The Future of Pharmaceutical Contract Development and Manufacturing Market
According to MarketsandMarkets, the global pharmaceutical contract development and manufacturing market is projected to reach USD 126.63 billion by 2024 … Keep Reading
Popularity of Generic Drugs Poised to Overshadow Atherosclerosis Drugs Market Growth
According to a report, the global atherosclerosis drugs market was valued at ~US$ 45.7 Bn in2018, and is expected to expand at a CAGR of2.5% during the forecast period of 2019 to 2027. Atherosclerosis is one of the major causes of cardiovascular diseases, and some causative comorbidities associated with it are obesity, diabetes, overweight, unhealthy diet, high blood pressure, and elevated levels of cholesterol. Various drugs, such as statins, are the first line treatment for atherosclerosis. Apart from this, fibrates, calcium channel blockers, beta blockers,…
You might be interested in
The UK is a Leader in Early Clinical Trials, but Falls Short in Further Research
A new report from the Association of the British Pharmaceutical Industry has determined that the United Kingdom leads Europe in early clinical phases but falls short when it comes to later stage studies.
You might be interested in
The Future of Pharmaceutical Contract Development and Manufacturing Market
According to MarketsandMarkets, the global pharmaceutical contract development and manufacturing market is projected to reach USD 126.63 billion by 2024 from USD 90 billion in 2019, at a CAGR of 7.1% during the forecast period. Growth in this market is driven by the rising demand for generics, increasing investments in pharmaceutical R&D, and investments in advanced manufacturing technologies by CDMOs. Also, the increasing demand for biological therapies, growing focus on specialty medicines, growth in the nuclear medicines sector, and advancements…
You might be interested in
